NM_006493.4:c.935T>C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_006493.4(CLN5):c.935T>C(p.Phe312Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000041 in 1,609,538 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F312L) has been classified as Uncertain significance.
Frequency
Consequence
NM_006493.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, short stature, facial anomalies, and joint dislocationsInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CLN5 | NM_006493.4 | c.935T>C | p.Phe312Ser | missense_variant | Exon 4 of 4 | ENST00000377453.9 | NP_006484.2 | |
| CLN5 | NM_001366624.2 | c.*384T>C | 3_prime_UTR_variant | Exon 5 of 5 | NP_001353553.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLN5 | ENST00000377453.9 | c.935T>C | p.Phe312Ser | missense_variant | Exon 4 of 4 | 1 | NM_006493.4 | ENSP00000366673.5 | ||
| ENSG00000283208 | ENST00000638147.2 | c.565+4700T>C | intron_variant | Intron 3 of 4 | 5 | ENSP00000490953.2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152252Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000810 AC: 20AN: 247028 AF XY: 0.0000674 show subpopulations
GnomAD4 exome AF: 0.0000419 AC: 61AN: 1457168Hom.: 0 Cov.: 33 AF XY: 0.0000359 AC XY: 26AN XY: 724530 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152370Hom.: 1 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74518 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neuronal ceroid lipofuscinosis 5 Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
The c.1082T>C (p.F361S) alteration is located in exon 4 (coding exon 4) of the CLN5 gene. This alteration results from a T to C substitution at nucleotide position 1082, causing the phenylalanine (F) at amino acid position 361 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30264640) -
Neuronal ceroid lipofuscinosis Uncertain:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 361 of the CLN5 protein (p.Phe361Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of neuronal ceroid lipofuscinosis (PMID: 30264640). ClinVar contains an entry for this variant (Variation ID: 580580). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CLN5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at